Sabine Krofczik-Wilhelm is a Senior Director in the Neuroscience Therapeutic Unit of the Clinical Research Group. Sabine is the Neurodegenerative Disorders Pillar Head. As a member of the Therapeutic Unit Senior Leadership Team Sabine is accountable for the strategic and operational delivery of the Neurodegenerative Disorders business. Sabine has a PhD in Neurobiology and has more than 13+ years experience in project management within pharmaceutical research and has worked in CRO environments. She was involved in the clinical development of ZEPOSIA® (ozanimod) a prescription medicine used to treat relapsing forms of multiple sclerosis (MS) and since more than 7+ years she is focusing on dementia clinical research.